Chairs
Current Chair: Neha Patel
Chair-elect candidate: Dania Alhamad
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
New Meds and Tech – Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes
June 25, 2026
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years…
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17)
June 23, 2026
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage…
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection
June 23, 2026
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by…